RENAL DATA FROM ASIA–AFRICA
|Year : 2018 | Volume
| Issue : 6 | Page : 1441-1451
|A review of the epidemiology of chronic kidney disease in Pakistan: A global and regional perspective
Salman Imtiaz, Beena Salman, Ruqaya Qureshi, Murtaza F Drohlia, Aasim Ahmad
Department of Nephrology, Dorab Patel Postgraduate Training and Research Center, The Kidney Center Postgraduate Training Institute, Karachi, Pakistan
Click here for correspondence address and email
|Date of Submission||11-Nov-2017|
|Date of Acceptance||26-Dec-2017|
|Date of Web Publication||27-Dec-2018|
| Abstract|| |
Both the incidence and prevalence of chronic kidney disease (CKD) are rising with immense pace worldwide. People living in developing countries are speculated to suffer the consequences due to economic deprivation and high cost of treatment. The prevalence of CKD is highly variable in different parts of the world, due to various environmental, ethnic, socioeconomical, and rural-urban differences. It has become very important for the developing countries to understand the true nature of the disease and its prevalence, rather than to hypothesize or make supposition on the bases of Western data. It is imperative to understand the risk factors in our region or country. Few studies have reported that the prevalence of CKD in Pakistan and its risk factors. Through the internet, we searched the terms prevalence of CKD, and included articles that discussed the CKD prevalence in different regions. We reviewed all studies along with the global as well as regional data to have better insight into the problem.
|How to cite this article:|
Imtiaz S, Salman B, Qureshi R, Drohlia MF, Ahmad A. A review of the epidemiology of chronic kidney disease in Pakistan: A global and regional perspective. Saudi J Kidney Dis Transpl 2018;29:1441-51
|How to cite this URL:|
Imtiaz S, Salman B, Qureshi R, Drohlia MF, Ahmad A. A review of the epidemiology of chronic kidney disease in Pakistan: A global and regional perspective. Saudi J Kidney Dis Transpl [serial online] 2018 [cited 2022 Dec 4];29:1441-51. Available from: https://www.sjkdt.org/text.asp?2018/29/6/1441/248307
| Introduction|| |
There is a major rise in the incidence of chronic kidney disease (CKD) all over the world. It was ranked 27th in the list of causes of total number of worldwide deaths in 1990, but rose to 18th in 2010. It is unique among other chronic ailments, due to its perplexing epidemiology. CKD significantly reduces the lifespan of a person by increasing the risk of cardiovascular mortality and its progression to end-stage renal disease (ESRD). In a comprehensive review and meta-analysis, the world-wide prevalence of CKD was found to be 23.4% in Stage 1–5 and 10.6% in Stage 3–5.
| Global Review|| |
A gross regional difference in the prevalence of CKD has been observed globally. For example, in the United States, the adjusted prevalence of CKD Stages 3 to 5 in adult white general population ranged from 4.3% in the states of Delaware and Pennsylvania to 16.7% in Florida. Among African-Americans, it ranged from 6.7% in California to 13.4% in the Mid-west states. Similar heterogeneity has been observed across European countries. For example, the adjusted prevalence of CKD Stages 1 to 5 varied between 3.31% in Norway and 17.3% in northwest Germany and the adjusted prevalence of CKD Stages 3 to 5 varied between 1.0% in central Italy and 5.9% in northwest Germany. Likewise, in Asian countries, for example in China, the adjusted prevalence of CKD Stages 1 to 5 showed large variation from 6.7% in south China to 18.3% in southwest China. The factors which can contribute in this observed variability could be an error in the sampling technique of the study which gathered an unrepresentative population, the differences in demographic characteristics of the population, for example, ethnicity and response rate of the population, difference in laboratory technique to measure creatinine and type of equation used to measure the estimated glomerular filtration rate (eGFR).
Diabetes mellitus (DM), hypertension (HTN), obesity and cardiovascular disease have attributed to the rapid rise in the incidence of CKD in most parts of the world, especially in developing countries. It is speculated that the prevalence of CKD will increase in future, because of the increase in the burden of risk factors in this region. This increase in CKD load puts prevention strategy as a most appropriate approach in this part of the world. Despite the increasing prevalence of DM, HTN and obesity globally, and their effects on increasing the prevalence of CKD, there are examples where these rising trends are now reverting, at least in some developed countries. For example, in the USA and Norway, the prevalence of CKD has not increased, rather stabilized in the last decade and has even reduced in the United Kingdom. The possible explanation for this is better control of HTN and DM and use of angiotensin-converting enzyme inhibitors in the last decade. There has been a remarkable change in clinical practice in the last decade; for example, understanding of blood pressure targets in DM for instance. When the UKPDS trial was conducted in 1980, it was an acceptable idea to allow patients with type-2 DM in the control arm to have blood pressure as high as 200/105 mm Hg which, according to the JNC-7, has now been reduced to <130/80 mm Hg. Similarly, there seems to be a better control of DM by targeting a lower HBA1c in the general population over time.
Another very interesting aspect of the epidemiology CKD is the discrepancy between the various CKD risk factors and the prevalence of CKD in different parts of the world. The magnitude of this discrepancy clearly points out that there are still undefined risk factors which modify the risk for CKD. For example, developing countries such as Poland, northern Tanzania, Italy, and India had a CKD prevalence of 5.8%, 7.0%, 7.1%, and, 7.5%, respectively, but had a higher prevalence of HTN 31.9%, 28.0%, 50.1%, 32.5%, and DM 6.7%, 12.7%, 11.8%, 19.0%, respectively. In contrast, in developed countries such as Australia, England, Canada, and USA where the overall prevalence of CKD is high 11.5%, 11.9% 12.5%, and 13.0%, respectively, the prevalence of HTN (29.0%, 34.1%, 16.3%, 27.1%, respectively) and DM (8.5%, 7.4%, 6.3% and 6.8%, respectively) was lower [Table 1].
|Table 1: Comparison of chronic kidney disease, hypertension, diabetes mellitus prevalence in developing and developed countries.|
Click here to view
This discrepancy indicates that genetic and environmental risk factors such as ethnicity, industrial pollution, low birth weight, infection, herbal medications and, dietary habits, deserve attention to explain the local prevalence of CKD [Table 1].
| Regional Review|| |
CKD in the South Asian region has the same pattern of widely varying prevalence as observed in developed countries. The causes of CKD are different and some of the regions have shown a high prevalence of CKD caused by glomerulonephritis and obstructive nephro-pathy and those of unknown etiology. To this date, very few studies have been conducted to evaluate the epidemiology of CKD in this region. India is now in a process of developing a CKD registry. In India, although the data are sparse, a few population-based studies have been performed. These studies have shown variable results; however, they at least give some idea for future planning. For example, in a study conducted in Delhi, investigators found a prevalence of 0.785% of CKD Stage-3 and above, as compared with another study carried out in Northern India, where it was 4.2%. On the other hand, in another study from Agra city, the prevalence of CKD Stage 1–3 was 13% as compared with the SEEK trial conducted all over India, wherein the prevalence of CKD Stages 1–5 was 17.2% [Table 2].
| Chronic Kidney Disease in Pakistan|| |
The epidemiology of CKD and its risk factors are not well studied in Pakistan, and very few hospital-based studies have been performed in the past. These studies have shown that DM and HTN are the major causes of CKD in urban areas while CKD of unknown etiology, glomerulonephritis and kidney stones were prevalent in the rural areas., The incidence of DM is also increasing in this region due to various reasons mentioned in the literature. This increased prevalence of DM in the community is manifested by an increased number of diabetic patients who are coming to the nephrology clinics with nondiabetic kidney disease. In a biopsy series of 212 diabetic patients, 91 (42.9%) were having nondiabetic kidney disease, while 45 (21.2%) had non-diabetic lesions with the background of diabetic kidney disease. In another study from the same city, in a renal biopsy series of 62 diabetic patients, 34 patients (52%) had non-diabetic kidney disease.
| Prevalence of Diabetes|| |
Since DM has emerged as a leading cause of CKD, the prevalence of DM as well as HTN has become an important factor to predict the future burden of CKD. There were two large community-based studies that were conducted to evaluate the prevalence of DM, which are worth mentioning here. The National Health Survey of Pakistan was conducted between 1990 and 1994, while Pakistan National Diabetic Survey was performed between 1994 and 1998 in all four provinces of the country. The national health survey of Pakistan was patterned on Third National Health and Nutrition Examination Survey, USA., The rural and urban areas of each of four provinces of Pakistan were taken as strata. A total of 18,315 persons were examined. This data were compared with the health status of the USA and Pakistan which obviously showed the gross differences in all indicators and parameters which a well-developed country and a developing country may have. The most important message or conclusion which emerged out from this landmark study was the conception at that time, that Pakistan was experiencing first, a “Double Burden,” one in which diseases associated with under development such as infectious diseases and nutritional deficiencies had not yet been controlled, along with risk factors for diseases associated with development such as cardiovascular diseases and cancer risk factors, which were also significant. Second, important inequalities also exist within Pakistan both between urban and rural residents and between economic status groups.
After 10 years of publishing this remarkable study, Jafar et al reanalyzed the data on many aspects such as DM, obesity, proteinuria, HTN in five ethnic groups. This distinguished work gave important insight into the volume of these important conditions at community level. They found an overall prevalence of DM of 5.4%, this was highest among Muhajirs (5.7%) and lowest among Baluchis (2.9%) [Table 3]. Similarly, central obesity was also evaluated and found important ethnic differences. The overall mean waist circumference was 79.5 (11.9%) and the age-standardized waist circumference was highest in Sindhis and Muhajir women; 81.9 (12.2%) and 81.8 (12.6%), respectively [Table 3].
|Table 3: Analysis of National health survey of Pakistan data by Jafar et al in five ethnic groups of Pakistan between 1990 and 1994.|
Click here to view
As mentioned earlier, the second largest study was performed by the Pakistan National Diabetic Survey, which included all four provinces between 1994 and 2000.,,,, The prevalence in the provinces of Sind, Baluchistan, Punjab and NWFP [Khyber Pakhtunkhwa (KPK)] is shown in [Table 4].
|Table 4: Studies performed by Shera et al in four provinces of Pakistan between 1994 and 1998.|
Click here to view
Both studies were performed in the same decade and apparently Jafar et al underestimated and Shera et al overestimated the prevalence of DM as evident from the recently completed diabetic survey of Pakistan 2017 which showed a prevalence of 26% (19 August 2017 newspapers). Both showed a gross difference in the overall prevalence of DM; Shera et al showed a relatively high prevalence of DM.
| Prevalence of Hypertension|| |
The prevalence of HTN was also evaluated by Jafar by analyzing National Health Survey of Pakistan (NHSP) data in five ethnic groups. They found that HTN was more prevalent in urban (22.7%) versus rural dwellers (18.1%), and the age-standardized prevalence of HTN was highest among Baluchi women (41%) and lowest among Sindhi women (9.9%) [Table 3].
| Prevalence of Chronic Kidney Disease|| |
CKD was evaluated at community level in few studies. Jafar et al. evaluated the prevalence of proteinuria, which is one of the markers of CKD, in five ethnic groups. They found the highest prevalence among Sindhis (men 9.5%, women 10.3%) and Muhajirs (men 8.2%, women 4.7%) and lowest prevalence among Baluchis (men 2.4% and women 4.2%) and the Pashtuns (men 2.5%, women 1.2%) [Table 3].
The prevalence of DM appears to reflect the ethnic distribution of proteinuria, while it did not show any association with HTN. The study has the following limitations: first, its cross-sectional design, second, only urinary protein was measured and third, serum creatinine was not performed, and therefore, only stage 1 kidney disease was evaluated. One thing that was very obvious from this novel study was that strong ethnic differences existed in the odds for proteinuria.
The prevalence of CKD was also evaluated in a community-based cross-sectional study conducted by Jessani et al, in Karachi, the largest metropolitan city of Pakistan. The study was not designed to measure the prevalence of CKD, rather it was a secondary analysis of the study, which was performed to promote intervention that can ensure blood pressure control at community level. The data were collected through a factorial design cluster randomized controlled trial. In a population of 3143 adults aged 40 years or older, they found a crude prevalence of reduced eGFR [eGFR CKD-Epi (pk) <60.0 mL/min 1.73 m2] in 5.3% (4.5%–6.2%), albuminuria (UACR ≥ μg/mmol) in 9.4% (8.4%–10.5%) and CKD in 12.5% (11.4%–13.8%) of the patients. The prevalence of CKD and reduced eGFR was higher in women compared to men, and it increased with age. When the CKD prevalence was standardized with age, it turned out to be 15.3% (13.7%–16.9%) while that of reduced eGFR and albuminuria, was 7.4% (6.2%–8.6%) and 11.1% (9.8%–12.4%), respectively. In another study, Jafar et al evaluated 262 subjects > 40 years of age, from a Pashtun community of Karachi, to determine the prevalence of reduced GFR. They found an overall prevalence of reduced GFR of 29.9% (24.2% to 35.1%) in men and 32.5% (24.8%–41.3%) in women.
| Chronic Kidney Disease of Unknown Etiology|| |
It is not uncommon for a nephrologist to encounter young patients with bilateral small sized kidneys with no associated comorbid conditions. The etiology remains unknown despite all possible clinical and laboratory work-up. CKD of unknown etiology is recognized as a severe form of kidney disease. It causes considerable morbidity and mortality, resulting in death in young and middle-aged patients, without any known etiological factors for CKD, such as DM and HTN. The exact risk factors are not known but attributed to occupational or environmental exposure and low birth weight.
This form of nephropathy is typically reported from regions which are warm, located in low altitude in coastal and tropical and subtropical regions. Recently, four forms have been recognized in different regions of the world including, Mesoamerican nephropathy, Sri Lankan nephropathy, Uddanam nephro-pathy of India, and El-mina nephropathy of Egypt. Characteristically, the disease is prevalent in rural inhabitants of low socioeconomic status, especially in males working in agricultural fields. Typically, all regional nephropathies have a histological appearance of chronic tubulointerstitial nephritis and mostly, the clinical features have similarities, such as late presentation, a long asymptomatic phase, nonglomerular proteinuria and an absence of HTN at the beginning of the disease. Chronic tubulointerstitial nephritis is the biopsy finding in most of the studies mentioned above. In Pakistan, despite massive urbanization, the population in rural areas is >60% in all four provinces, and most of them rely on agriculture as their occupation. The climate is hot in these areas. In an analysis of kidney biopsy, pathological data of 1200 patients performed at our center, it was shown that chronic tubulointerstitial nephropathy was found in 11% of the patients. In a further analysis of those who had been diagnosed to have tubulointerstitial nephropathy (unpublished data), we found that most patients presented with similar clinical features and were from rural areas. The exact cause of kidney injury, such as water deprivation due to excessive sweating in warm humid climate, or drinking plenty of contaminated water, still remains a question.
Contamination of drinking water with heavy metals, such as Cadmium (Cd) and Arsenic (As) has been recognized as nephropathic due to their oxidative stress. In a cross-sectional case–control study of more than 6000 individuals, which included 733 cases and 4044 controls from endemic and non-endemic areas, Jaylilka and Mendis found significantly higher urinary excretion of Cd in individuals with CKD compared with controls in endemic areas, 1.039 μg/g versus 0.646 μg/g, respectively; it was 0.345 μg/g in non-endemic areas. They also found a dose-effect relationship between urinary Cd concentration and CKD stages. They advocated that Cd exposure is a risk factor for the pathogenesis of CKD. In a Mexican study of 90 individuals with no previous comorbid conditions, Robles-Osorio and Pérez-Maldonado found a strong correlation between urinary arsenic excretions and αl microglobulin excretion.
In Pakistan, the status of drinking water contaminated with As and Cd is alarming. Abbas and Cheema analyzed 100 drinking water samples from District Sheikhupura, Punjab and found high mean value of As concentration in hand pump sample of 76.22 ± 20.73 ppb and lower in bottle water of 7.742 ± 3.066 ppb as compared with WHO standard of 10 ppb.
Similar high levels different heavy metals have been found in the Sindh province; Arain et al found high levels of 96 μg/L in ground-water and 157 μg/L in surface water. The Pakistan Council of Research in Water Resources (PCRWR 2015–16) evaluated the status of As level regularly in major cities of Pakistan. Due to persistent and increasing contamination of As, a national action plan to mitigate the As effect was introduced between 2007 and 2011. In the Manchar Lake, which is the largest reservoir of the fresh water in Pakistan, the As level was found to range from 35.2–158 μg/L, which is 3–15 fold higher than the limit. Similarly, in Jamshoro, Sindh the highest content of As in surface water sample was found to be 50 μg/L.,
Cd, as discussed above, is also a great concern due to its renal and other toxicities. The safe standard for Cd concentration in drinking water by WHO is 0.0003 ng/L. In Pakistan, high Cd concentration in drinking water was found from effluent discharges of marbles, steel, mining, metal, planting, and aluminum industry. High concentration of Cd was found from many samples collected from different parts of the country. The concentration of Cd in groundwater samples collected from various sites of Pakistan ranged from 0.001 to 0.2 μg/L. The highest value of 0.21 mg/dL was reported in the sample collected from tubewell water of Hayatabad Industrial Estate, KPK. There is large variation in Cd concentration of surface water throughout the country.,
Low birth weight
Low birth weight (LBW) is associated with high risk of ESRD in the 3rd and 4th decades of life. It is estimated that 72% of LBW infants in developing countries are born in Asia. Although there is no study on the prevalence of low birth weight in Pakistan, UNICEF estimates an incidence of 19%. With this high incidence of low birth weight, it will be pivotal to look for this association in this region as well.
Kidney stone disease
Kidney stones are still among the leading cause of kidney failure in Pakistan., Both incidence and prevalence of kidney stones is increasing worldwide. Dietary factors play an important role both in developing and the developed world., Stone disease increases the risk of CKD, albeit not causing ESRD significantly. In a study of 360 patients from a tertiary care hospital of Karachi, Naqvi and Rizvi found that 242 (67%) of the patients had renal failure, 48 (13.33%) remained on hemodialysis, 11 (3.05%) underwent kidney transplant and 58 (16.11%) died from the disease. Similarly, in the pediatric population, high rate of CKD was noted due to delay in detection of kidney stones. Khan et al reported that 16% of the patients who came to their center with kidney stones developed CKD. Likewise, Rizvi et al found that 20% of their pediatric patients who underwent kidney transplantation developed ESRD due to kidney stones.
| Conclusion|| |
This review shows that the pattern of CKD and its risk factors such as DM and HTN is similar to that seen in other parts of the world. There is a wide fluctuation and uncertainty in reporting the prevalence in different studies globally as well as regionally. The number of studies performed in Pakistan is few, under powered, not representative of the population and primarily not designed to evaluate the prevalence of CKD. These studies showed a prevalence of DM of 5.5%–22%, HTN of 19.8% and CKD of 5.0% to 12.5% to 31.2%. The prevalence of CKD is high in women and increases with age in both genders. There is a large population in whom the exact cause of renal failure is obscure, and possibility of environmental factors such as water contamination, low birth weight, and kidney stone disease should be evaluated in large community-based studies.
| Acknowledgment|| |
We greatly acknowledge the support of Ms. Yumna Maheen for reviewing the manuscript.
Conflict of interest: None declared.
| References|| |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012:380:2095-128.
Gensevoort RT. Chronic kidney disease and CVD mortality. JAMA 2007:298:2038.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease -A systematic review and meta-analysis. PLoS One 2016;11:e0158765.
Tanner RM, Gutiérrez OM, Judd S, et al. Geographic variation in CKD prevalence and ESRD incidence in the United States: Results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis 2013:61:395-403.
Brück K, Stel VS, Gambaro G, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 2016:27:2135-47.
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012:379:815-22.
Zdrojewski L, Zdrojewski T, Rutkowski M, et al. Prevalence of chronic kidney disease in a representative sample of the polish population: Results of the NATPOL 2011 survey. Nephrol Dial Transplant 2016:31:433-9.
Stanifer JW, Maro V, Egger J, et al. The epidemiology of chronic kidney disease in Northern Tanzania: A population-based survey. PLoS One 2015:10:e0124506.
De Nicola L, Donfrancesco C, Minutolo R, et al. Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: Results of the 2008-12 National Health Examination Survey. Nephrol Dial Transplant 2015:30:806-14.
Anand S, Shivashankar R, Ali MK, et al. Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. Kidney Int 2015:88:178-85.
White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study GFR estimating equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) study. Am J Kidney Dis 2010:55: 660-70.
Fraser SD, Aitken G, Taal MW, et al. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS One 2015:10:e0118676.
Arora P, Vasa P, Brenner D, et al. Prevalence estimates of chronic kidney disease in Canada: Results of a nationally representative survey. CMAJ 2013:185:E417-23.
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007:298:2038-47.
Jha V, Wang AY, Wang H. The impact of CKD identification in large countries: The burden of illness. Nephrol Dial Transplant 2012:27 Suppl 3:iii32-8.
Hallan SI, Øvrehus MA, Romundstad S, et al. Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int 2016:90:665-73.
Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 2016:165:473-81.
Aitken GR, Roderick PJ, Fraser S, et al. Change in prevalence of chronic kidney disease in England over time: Comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open 2014:4: e005480.
Tight blood pressure control and risk of macro-vascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group. BMJ 1998:317:703-13.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003:289:2560-72.
Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014:160:517-25.
Ibrahim G. Chronic kidney disease hotspot in developing countries in South Asia. Clin Kidney J 2016:9:135-41.
Rajapurkar MM, John GT, Kirpalani AL, et al. What do we know about chronic kidney disease in India:First report of the Indian CKD registry. BMC Nephrol 2012:13:10.
Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005;20:1638-42.
Singh NP, Ingle GK, Saini VK, et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: An observational, cross-sectional study. BMC Nephrol 2009;10:4.
Varma PP, Raman DK, Ramakrishnan TS, Singh P, Varma A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol Dial Transplant 2010;25:3011-7.
Singh AK, Farag YM, Mittal BV, et al. Epidemiology and risk factors of chronic kidney disease in India – Results from the SEEK (Screening and early evaluation of kidney disease) study. BMC Nephrol 2013;14: 114.
Rizvi SA, Manzoor K. Causes of chronic renal failure in Pakistan: A single large center experience. Saudi J Kidney Dis Transpl 2002; 13:376-9.
] [Full text]
Salman B, Imtiaz S, Qureshi R, Dhrolia MF, Ahmad A. The causes of chronic kidney disease in adults in a developing country. J Nephrol Ren Dis 2017;1:1.
Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: An update. Diabetes Res Clin Pract 2014;103:231-7.
Salman B, Imtiaz S, Qureshi R, Dhrolia MF, Ahmad A. The contemporary scope of renal histopathology in diabetic patients-analysis of kidney biopsy in single centre. J Nephrol Ren Dis 2017;1:2.
Yaqub S, Kashif W, Hussain SA. Non-diabetic renal disease in patients with type-2 diabetes mellitus. Saudi J Kidney Dis Transpl 2012;23: 1000-7. [Full text]
Pappas G, Akhtar T, Gergen PJ, Hadden WC, Khan AQ. Health status of the Pakistani population: A health profile and comparison with the United States. Am J Public Health 2001;91:93-8.
Mallick MD. Sample design for the National Health Survey of Pakistan. Pak J Med Res 1992;31:289-90.
Jafar TH, Levey AS, White FM, et al. Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan. Diabet Med 2004;21:716-23.
Jafar TH, Levey AS, Jafary FH, et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens 2003;21:905-12.
Jafar TH, Chaturvedi N, Gul A, Khan AQ, Schmid CH, Levey AS. Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan. Kidney Int 2003; 64:1437-44.
Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007;76:219-22.
Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. Pakistan national diabetes survey: Prevalence of glucose intolerance and associated factors in Shikarpur, Sindh province. Diabet Med 1995;12:1116-21.
Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan national diabetes survey: Prevalence of glucose intolerance and associated factors in Baluchistan province. Diabetes Res Clin Pract 1999;44:49-58.
Shera AS, Basit A, Fawwad A, et al. Pakistan national diabetes survey: Prevalence of glucose intolerance and Associated factors in the Punjab province of Pakistan. Prim Care Diabetes 2010;4:79-83.
Shera AS, Rafique G, Khwaja IA, Baqai S, Khan IA, King H. Pakistan National Diabetes Survey prevalence of glucose intolerance and associated factors in North West at Frontier Province (NWFP) of Pakistan. J Pak Med Assoc 1999;49:206-11.
Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan – A community based cross-sectional study. BMC Nephrol 2014;15:90.
Jafar TH, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country: A cluster randomized trial. Ann Intern Med 2009;151:593-601.
Jafar TH, Schmid CH, Levey AS. Serum creatinine as marker of kidney function in South Asians: A study of reduced GFR in adults in Pakistan. J Am Soc Nephrol 2005; 16:1413-9.
Kupferman J, Amador JJ, Lynch KE, et al. Characterization of Mesoamerican nephro-pathy in a kidney failure hotspot in Nicaragua. Am J Kidney Dis 2016;68:716-25.
Jayasumana C, Gunatilake S, Siribaddana S. Simultaneous exposure to multiple heavy metals and glyphosate may contribute to Sri Lankan agricultural nephropathy. BMC Nephrol 2015;16:103.
Ganguli A. Uddanam nephropathy/regional nephropathy in India: Preliminary findings and a plea for further research. Am J Kidney Dis 2016;68:344-8.
El Minshawy O. End-stage renal disease in the El-Minia Governorate, upper Egypt: An epide-miological study. Saudi J Kidney Dis Transpl 2011;22:1048-54.
Weaver VM, Fadrowski JJ, Jaar BG. Global dimensions of chronic kidney disease of unknown etiology (CKDu): A modern era environmental and/or occupational nephropathy? BMC Nephrol 2015;16:145.
Imtiaz S, Drohlia MF, Nasir K, Salman B, Ahmad A. Analysis of renal diseases detected in renal biopsies of adult patients: A single-center experience. Saudi J Kidney Dis Transpl 2017;28:368-78.
] [Full text]
Huang M, Choi SJ, Kim DW, et al. Risk assessment of low-level cadmium and arsenic on the kidney. J Toxicol Environ Health A 2009;72:1493-8.
Jayatilake N, Mendis S, Maheepala P, Mehta FR; CKDu National Research Project Team. Chronic kidney disease of uncertain aetiology: Prevalence and causative factors in a developing country. BMC Nephrol 2013;14:180.
Robles-Osorio ML, Pérez-Maldonado IN, Martín del Campo D, et al. Urinary arsenic levels and risk of renal injury in a cross-sectional study in open population. Rev Invest Clin 2012;64:609-14.
Abbas M, Cheema KJ. Arsenic levels in drinking water and associated health risk in district Sheikhupura, Pakistan. J Anim Plant Sci 2015;25:719-24.
Arain MB, Kazi TG, Jamali MK, et al. Evaluation of physicochemical parameters of Manchar Lake water and their comparison with other global published values. Pak J Anal Environ Clean 2008;9:101-9.
Arain MB, Kazi TG, Baig JA, et al. Determination of arsenic levels in lake water, sediment, and foodstuff from selected area of Sindh, Pakistan: Estimation of daily dietary intake. Food Chem Toxicol 2009;47:242-8.
Pakistan Council of Research in Water Resources (PCRWR). Water quality status in Pakistan, 1st
Report 2001-2002. Pakistan Council of Research in Water Resources; 2002.
NAPAM 2007-2011 National Data Plan Arsenic Mitigation, Pakistan Water and Sanitation Gateway. Ministry of Environment, Government of Pakistan; 2007-2011.
Tariq M, Ali M, Shah Z. Characteristics of industrial effluent and their possible impacts on quality of underground water. Soil Environ 2005;25:64-9.
Saif MS, Haq M, Memon KS. Heavy metals contamination through industrial effluent to irrigation water and soil in Korangi area of Karachi (Pakistan). Int J Agric Biol 2005;7: 646-8.
Lone MI, Saleem S, Mahmood T, Saifullah K, Hussain G. Heavy metal contents of vegetables irrigated by sewage/tube-well water. Int J Agric Biol 2003;5:533-5.
Manzoor S, Shah MH, Shaheen N, Khalique A, Jaffar M. Multivariate analysis of trace metals in textile effluents in relation to soil and groundwater. J Hazard Mater 2006;137:31-7.
Tariq SR, Shah MH, Shaheen N, Khalique A, Manzoor S, Jaffar M. Multivariate analysis of trace metal levels in tannery effluents in relation to soil and water: A case study from Peshawar, Pakistan. J Environ Manage 2006; 79:20-9.
Yousafzai AM, Khan AR, Shakoori AR. Heavy metal pollution in River Kabul affecting the inhabitant fish population. Pak J Zool 2008; 40:331-9.
Mastoi GM, Shah SG, Khuhawar MY. Assessment of water quality of Manchar Lake in Sindh (Pakistan). Environ Monit Assess 2008;141:287-96.
Ruggajo P, Skrunes R, Svarstad E, Skjærven R, Reisæther AV, Vikse BE. Familial factors, low birth weight, and development of ESRD: A nationwide registry study. Am J Kidney Dis 2016;67:601-8.
Wardlaw T, Blanc A, Zupan J. LBW: Country, Regional and Global Estimate. New York: World Health Organization, UNICEF; 2004.
Talati J, Khan H, Drago A, et al. Epidemiology of urolithiasis in Pakistan. In: Talati J, Sutten RA, Moazam F, Ahmed M, editors. The Management of Lithiasis. Dordrecht. The Netherlands: Kluwer Academic Publishers; 1997. p. 21-33.
Romero V, Akpinar H, Assimos DG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol 2010;12:e86-96.
Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009;4:804-11.
Hussain M, Lal M, Ali B, et al. Management of urinary calculi associated with renal failure. J Pak Med Assoc 1995:45:205-8.
Khan AM, Hussain MS, Moorani KN, Khan KM. Urolithiasis associated morbidity in children. J Rawalpindi Med Coll 2014:18:73-4.
Rizvi SA, Naqvi SA, Hussain Z. Living-related pediatric renal transplant: A single-centre experience from a developing country. Pediatr Transplant 2002;6:101-10.
Dr. Salman Imtiaz
Department of Nephrology, Dorab Patel Postgraduate Training and Research Center, The Kidney Center Post Graduate Training Institute, Karachi
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Haemodialysis alters the serum metal contents in chronic kidney failure patients at hyderabad and adjoining areas
| ||Marvi Shaikh, Naseem Aslam Channa, Ali Muhammad Wahryah, Muhammad Haneef Mugheri, Shakil Samejo, Lubna Noorani |
| ||BioMetals. 2022; |
|[Pubmed] | [DOI]|
||Chronic kidney disease causes and outcomes in children: Perspective from a LMIC setting
| ||Farhana Amanullah, Amyn A. Malik, Zafar Zaidi, Carla Pegoraro |
| ||PLOS ONE. 2022; 17(6): e0269632 |
|[Pubmed] | [DOI]|
||Awareness of Chronic Kidney Disease, Medication, and Laboratory Investigation among Nephrology and Urology Patients of Quetta, Pakistan
| ||Jahanzaib Ahmed, Saira Azhar, Noman ul Haq, Sajjad Hussain, Anette Stájer, Edit Urbán, Márió Gajdács, Shazia Jamshed |
| ||International Journal of Environmental Research and Public Health. 2022; 19(9): 5015 |
|[Pubmed] | [DOI]|
||Morphological Spectrum of Glomerulonephritis in Medical Renal Biopsies: A Single-Center Study
| ||Zubaria Rafique, Safana Sadaf, Saima Batool, Saira Javeed, Akhtar S Chughtai, Aribah Atiq |
| ||Cureus. 2022; |
|[Pubmed] | [DOI]|
||Frequency of Subclinical Hypothyroidism in Patients With Chronic Kidney Disease
| ||FNU Anum, Aasta Kumari, Mehak Gul, Shilpa Bai, Muhammad Haseeb, Kanza Mirza Maqsood, Amna Jamil, Faizan Shaukat, Maha Jahangir |
| ||Cureus. 2022; |
|[Pubmed] | [DOI]|
||International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia
| ||Smita S. Divyaveer, Raja Ramachandran, Manisha Sahay, Dibya Singh Shah, Fazal Akhtar, Aminu K. Bello, Arpana Iyengar, David W. Johnson, David C.H. Harris, Adeera Levin, Meaghan Lunney, Muhibur Rahman, Harun-Ur Rashid, Syed Saad, Deenaz Zaidi, Mohamed A. Osman, Santosh Varughese, Eranga S. Wijewickrama, Maryam Khan, Feng Ye, Marcello Tonelli, Ikechi G. Okpechi, Vivekanand Jha |
| ||Kidney International Supplements. 2021; 11(2): e97 |
|[Pubmed] | [DOI]|
||Syndemics at play: chronic kidney disease, diabetes and COVID-19 in Pakistan
| ||Inayat Ali |
| ||Annals of Medicine. 2021; 53(1): 581 |
|[Pubmed] | [DOI]|
||Bone Marrow Findings in Renal Patients: A Single Renal Specialist Center Experience
| ||Kiran Nasir, Ruqaya Qureshi, Hina Qureshi, Murtaza Dhrolia, Aasim Ahmad |
| ||Cureus. 2021; |
|[Pubmed] | [DOI]|
||Ensemble Feature Ranking for Cost-Based Non-Overlapping Groups: A Case Study of Chronic Kidney Disease Diagnosis in Developing Countries
| ||Syed Imran Ali, Hafiz Syed Muhammad Bilal, Musarrat Hussain, Jamil Hussain, Fahad Ahmed Satti, Maqbool Hussain, Gwang Hoon Park, Taechoong Chung, Sungyoung Lee |
| ||IEEE Access. 2020; 8: 215623 |
|[Pubmed] | [DOI]|
||Determining the Frequency of Acquired Cystic Kidney Disease in End Stage Renal Disease Patients on Hemodialysis at Dialysis Centre of Tertiary Care Hospital
| ||Muhammad Aleem, Khurram Saleem, Sana Zafar, Amina Umer, Rabia Arshad, Arsalan Nawaz |
| ||Cureus. 2020; |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||12081 |
| Printed||46 |
| Emailed||0 |
| PDF Downloaded||987 |
| Comments ||[Add] |
| Cited by others ||10 |